Back

The Fas-FADD-caspase-8 axis is a cancer cell-intrinsic determinant of cytotoxic lymphocyte-mediated killing

Solli, E.; Wang, S.; Wei, Q.; Saidu, N. E. B.; Tasken, K.; Li, Y.

2026-06-17 immunology
10.64898/2026.06.14.732110 bioRxiv
Show abstract

Cytotoxic lymphocytes induce cancer cell death through death receptor-ligand interactions and the perforin-granzyme pathway. These pathways are generally thought to converge on the activation of executioner caspases to drive apoptosis. Here, we employed a reductionist approach to systematically disrupt key cell death mediators in a cytotoxic lymphocyte killing system to define their roles in determining cancer cell fate. We found that loss of executioner caspases conferred only limited resistance to cytotoxic lymphocyte-mediated killing. To identify cancer cell-intrinsic regulators that function beyond executioner caspases, we performed unbiased genome-wide CRISPR screens in executioner caspase-deficient cells. Unexpectedly, disruption of Fas or FADD--core components of the death receptor pathway--conferred substantial resistance to cytotoxic lymphocyte-mediated killing even in the absence of executioner caspases. This resistance persisted following additional disruption of known downstream mediators of Fas-FADD-caspase-8 (CASP8) signaling. Together, these findings identify the Fas-FADD-CASP8 axis as a central cancer cell-intrinsic determinant of susceptibility to cytotoxic lymphocyte-mediated killing whose function is not fully explained by canonical apoptotic or non-apoptotic effector pathways. Our results further suggest that CASP8 engages additional downstream substrates or mechanisms to promote cytotoxic lymphocyte-induced cancer cell death.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
eLife
5828 papers in training set
Top 2%
22.5%
2
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 0.8%
19.0%
3
Science Signaling
65 papers in training set
Top 0.1%
8.1%
4
Cell Reports
1498 papers in training set
Top 6%
5.7%
50% of probability mass above
5
Nature Communications
5641 papers in training set
Top 33%
3.6%
6
EMBO Reports
263 papers in training set
Top 2%
2.5%
7
Scientific Reports
3612 papers in training set
Top 41%
2.5%
8
PLOS Pathogens
820 papers in training set
Top 5%
2.5%
9
Cell Death & Differentiation
48 papers in training set
Top 0.4%
2.2%
10
Communications Biology
993 papers in training set
Top 13%
1.8%
11
Immunity
67 papers in training set
Top 1.0%
1.8%
12
Cell Death & Disease
21 papers in training set
Top 0.2%
1.8%
13
Science Immunology
88 papers in training set
Top 1%
1.7%
14
PLOS ONE
5266 papers in training set
Top 50%
1.5%
15
Cancer Immunology Research
35 papers in training set
Top 0.6%
1.4%
16
Journal of Biological Chemistry
690 papers in training set
Top 6%
1.4%
17
Science Advances
1243 papers in training set
Top 24%
1.2%
18
Frontiers in Immunology
638 papers in training set
Top 9%
0.9%
19
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 2%
0.9%
20
The EMBO Journal
309 papers in training set
Top 7%
0.6%
21
PLOS Biology
486 papers in training set
Top 13%
0.6%
22
Cell Chemical Biology
94 papers in training set
Top 2%
0.6%
23
Journal of Cell Biology
392 papers in training set
Top 4%
0.6%
24
Cancer Research
130 papers in training set
Top 3%
0.6%